Data / Form D filings / SUNESIS PHARMACEUTICALS INC
SUNESIS PHARMACEUTICALS INC: Form D filings
SUNESIS PHARMACEUTICALS INC, a pharmaceuticals company in South San Francisco, CA, filed 2 Form D notices with the SEC between 2009 and 2010. The latest, on July 14, 2010, reports $28.5 million sold of a $28.5 million offering to 18 investors.
Find out what SUNESIS PHARMACEUTICALS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 395 OYSTER POINT BOULEVARD, SUITE 400, South San Francisco, CA, 94080
- Phone
- (650) 266-3500
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1061027
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 14, 2010 | New notice | $28,500,000 | $28,500,000 | $0 | 18 | Jun 30, 2010 | sec.gov |
| Apr 17, 2009 | New notice | $15,000,000 | $10,000,000 | $5,000,000 | 18 | Apr 3, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Homer L. Pearce | Director | |
| Matthew K. Fust | Director | |
| Dayton K. Misfeldt | Director | |
| Daniel N., Jr. Swisher | Executive Officer, Director | |
| Eric H. Bjerkholt | Executive Officer | |
| David C. Stump | Director | |
| Helen Susan Kim | Director | |
| Steven H. Ketchum | Executive Officer | |
| Ed K. Hurwitz | Director | |
| James W. Young | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Jul 12, 2010 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what SUNESIS PHARMACEUTICALS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.